BREAKING NEWS: Second Circuit Chimes in on Nutraceutical Claim Substantiation
The Second Circuit recently breathed life back into a lawsuit about the adequacy of data used to support cognitive enhancement claims. Specifically, the court vacated a previous Southern District of New York dismissal of an FTC complaint alleging that Quincy Bioscience advertised the memory supplement “Prevagen” without a reasonable basis
Read More